ASCRS/SSAT Joint Symposium: Multidisciplinary Treatment of Inflammatory Bowel Disease

Tuesday, May 3, 10:15 - 11:45 am

CME Credit Hours: 1.5

In recent decades, tremendous progress has been made in the medical and surgical treatment of Inflammatory Bowel Diseases. In this symposium, we will review several hot topics of interest to all colorectal surgeons who care for IBD patients. First, we will examine the evolving role of the mesentery in the pathophysiology and potential effect on post-operative recurrence. Next, we will discuss how male and female fertility and sexual dysfunction after IPAA, and how the approach to dysplasia has evolved in recent years. Finally, almost all IBD patients benefit from preoperative optimization in terms of nutrition, anemia, and other modifiable risk factors, while we as surgeons benefit from lessons learned from our national NSQIP IBD collaborative.


At the conclusion of this session, participants should be able to:
  1. Recognize new approaches to dealing with Crohn’s mesentery
  2. Describe rates of, and treatments for, infertility and sexual dysfunction after IPAA
  3. Discuss the benefits of a national IBD registry on quality improvement for IBD surgery


Stefan Holubar, MD, Cleveland, OH

Konstantin Umanskiy, MD, Chicago, IL

Social Media
Jonathan Abelson, MD, Burlington, MA

10:15 am               
Stefan Holubar, MD, Cleveland, OH
Konstantin Umanskiy, MD, Chicago, IL
10:20 am               
A Better Resection? Extended Mesenteric Excision for Crohn’s Disease
Anthony De Buck Van Overstraeten, MD, Toronto, ON, Canada
10:27 am               
A Better Resection? The Kono-S Anastomosis
Alessandro Fichera, MD, Dallas, TX
10:34 am               
Questions and Answers
10:50 am               
Modern Approaches to Infertility & Sexual Dysfunction after IPAA
Karen Zaghiyan, MD, Los Angeles, CA
10:57 am               
Modern Management of Dysplasia in Ulcerative Colitis
Mukta Krane, MD, Seattle, WA
11:04 am            
Questions and Answers

11:19 am            
Preoperative Optimization of IBD Patients

Nell Maloney Patel, MD, New Brunswick, NJ        
11:26 am            
Neoadjuvant Biologics: When to Start and When to Stop    
David Stewart, Sr., MD, Springfield, IL
11:33 am            
Questions and Answers
11:45 am